Skip to content

Bruker BRKR Derivative Assets Liabilities At Fair Value Net

Derivative Assets Liabilities At Fair Value Net at other companies

Lennar logo
LennarLEN
-$3.86M+62.8%
McCormick & Company, Incorporated logo
McCormick & Company, IncorporatedMKC
-$18.7M+46.6%
Apollo Global Management logo
Apollo Global ManagementAPO
$5.43B+96.3%
Annaly Capital Management logo
Annaly Capital ManagementNLY
$387.02M
Rexford Industrial Realty logo
Rexford Industrial RealtyREXR
$4.56M-18.2%
Popular logo
PopularBPOP

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's derivative assets liabilities at fair value net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's derivative assets liabilities at fair value net?
Bruker (BRKR) reported derivative assets liabilities at fair value net of -$228.7M in Q1 2026.
How has Bruker's derivative assets liabilities at fair value net changed year-over-year?
Bruker's derivative assets liabilities at fair value net decreased by 339.0% year-over-year, from -$52.1M to -$228.7M.
What is the long-term trend for Bruker's derivative assets liabilities at fair value net?
Over 5 years (2020 to 2025), Bruker's derivative assets liabilities at fair value net has grown at a 23.8% compound annual growth rate (CAGR), from -$86.6M to -$252M.